Parenteral Drug Association
Connecting People, Science and Regulation ®
by: PDA, Inc.
by: Douglas Campbell
by: Qifeng Zhang, PhD, Lonza
PDA, Inc.
By: Douglas Campbell, InterPro QRA
By: Michael de la Torre
By: Louise Uí Fhatharta, Pharmalex
By: Qifeng Zhang, PhD, Lonza, Lonza Biologics
PDA
Justin Johnson, PDA
By: Enrico Barichello, Stevanato Group
By: Edward H. Trappler and Denise Miller, Lyophilization Technology
By: Ashley McMillan, Veeva Vault LIMS
By: Romain Veillon, GSK
By: Subrata Chakraborty, GxPfont Consulting Group , Vanessa Figueroa, VVF Science , and Marcia Baroni, Emergent BioSolutions Inc
By: Jason Kerr, Moderna
By: Austin Caudle, Redica Systems
By: Oliver Stauffer, PTI and Tyler Harris, PTI
By: Vishal Sharma, Vienni Training and Consulting LLP
By: Michelle Tu, Qvin
By: Antonio Burazer, Takeda
By: Bettine Boltres, PhD and Ana Marques Kuschel, WEST Pharmaceutical Services
By: Martin VanTrieste, Civica Rx
By: Kurt Jaecques, GSK and Erika Pfeiler, PhD, U.S. FDA
By: Laurent Jeanmart, PhD, GSK and Brigitte Reutter-Haerle
Walter Morris, PDA
By: Christoph Bredack, PhD, Genedata
Whitney Alexis, PDA
By: Robert Dream, Consultant and Bruce Loxley, GSK
By: Julian Petersen, groninger & co. gmbh
By: Lucia Ceresa, Consultant
Glenn E. Wright, PDA President and CEO
By: Morten Munk, Fujifilm Diosynth Biotechnologies , Virginia Boldt, Accenture , and Andrew Chang, PhD, PhD, Novo Nordisk
By: Sabine Hauck, Consultant and Elisabeth Vachette, Sartorius Stedim Biotech
By: Parampal Deol, PhD, Charles River Laboratories
By: Oliver Stauffer, PTI
By: Londa Ritchey and Patrick Nieuwenhuize, PharmaLex
Justin Johnson and Walter Morris, PDA
By: Cristiana Campa, PhD, Technical R&D Advisor at GSK and Sabrina Restrepo, Merck & Co.
By: Tony Cundell, PhD, Microbiological Consulting, LLC
By: Tejesh Marsale, PCI Pharma Services
By: Josh Russell, AST
By: Kent Malmros, Veeva Training Strategy and Iain Searle, Veeva Training Strategy
By: Emily Cheah, PhD, Charles River Laboratories-Singapore
By: Stephan Krause, PhD, Bristol Myers Squibb and Adam Boyer, Bristol Myers Squibb, Bristol Myers Squibb
By: Julian Petersen, groninger & co. gmbh and Richard Denk, SKAN AG
By: Rebecca Brewer, Quality Executive Partners
By: William Peterson, Merck
By: Toni Manzano, Aison
By: Ahmed Elsaid, Emergent Biosolution and Ajay Pazhayattil, PhD, cGMP World
By: Ron Branning, GXP Quality Systems, LLC, GXP Quality Systems, LLC
By: Hal Baseman, ValSource, Inc. and Gabriele Gori, Independent Consultant
By: Noelle Clifford, PharmaLex, PharmaLex
By: Antonio Burazer, Takeda , Alexander Artau, Sanofi , Elisabeth Wagner, CSL Behring , and Joseph Straub, Merck
By: Simone Biel, PhD, Merck, Merck
By: Philippe Lauwers, Terumo Pharmaceutical Solutions
By: Zachary Beck, Eurofins
By: Jason Kerr, Moderna , Katie Bevard, Amgen , and Maria Jacobs, PhD, Pfizer, Inc.
Walter Morris, PDA, Inc.
By: Renske ten Ham, PhD, UMC Utrecht and Richard Denk, SKAN AG